PIDTC: Investigating Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with P47phox Chronic Granulomatous Disease
Apr 24, 2024 ·
2m 3s
Sign up for free
Listen to this episode and many more. Enjoy the best podcasts on Spreaker!
Download and listen anywhere
Download your favorite episodes and enjoy them, wherever you are! Sign up or log in now to access offline listening.
Description
New research from the Primary Immune Deficiency Treatment Consortium (PIDTC). This summary is based on a paper published in the Journal of Allergy and Clinical Immunology on January 28, 2024,...
show more
New research from the Primary Immune Deficiency Treatment Consortium (PIDTC). This summary is based on a paper published in the Journal of Allergy and Clinical Immunology on January 28, 2024, titled "Allogeneic hematopoietic cell transplantation is effective for p47phox chronic granulomatous disease: A Primary Immune Deficiency Treatment Consortium study."
Read the paper here: https://www.jacionline.org/article/S0091-6749(24)00081-2/abstract
Learn more about PIDTC: https://pidtc.rarediseasesnetwork.org
show less
Read the paper here: https://www.jacionline.org/article/S0091-6749(24)00081-2/abstract
Learn more about PIDTC: https://pidtc.rarediseasesnetwork.org
Information
| Author | RDCRN |
| Organization | RDCRN |
| Website | - |
| Tags |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
